Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia
{{output}}
Interindividual variability in response to 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, with regard to both efficacy and safety is an obvious target for pharmacogenetic research. Many genes have been identified as possible contributo... ...